Page, Chloe E. http://orcid.org/0000-0001-5573-3760
Epperson, C. Neill
Novick, Andrew M.
Duffy, Korrina A. http://orcid.org/0000-0003-0377-0134
Thompson, Scott M. http://orcid.org/0000-0001-9844-9049
Article History
Received: 17 November 2023
Revised: 15 May 2024
Accepted: 21 May 2024
First Online: 31 May 2024
Competing interests
: CNE receives consulting feeds from Sage Therapeutics and Health Rhythms for Research unrelated to this manuscript. CNE participates on scientific advisory boards for Embark/Neuro and BabyScripts, and has unpaid roles with the National Network of Depression Centers (Member at Large), The Society of Biological Psychiatry (Council Member), and the American College of Neuropsychopharmacology (Executive Council). SMT is listed as an inventor on and receives royalties from patents related to treating depression that are held by the University of Maryland, Baltimore. SMT has received honoraria from several non-profit or academic institutions and from companies developing psychiatric drugs for general lectures and advice about depression treatments. SMT has patents issued and pending from the University of Maryland, Baltimore, for various means for treating depression. SMT serves as an unpaid member of several committees for the American College of Neuropsychopharmacology. AMN is supported by the National Institute of Child Health and Development K23HD110435. CEP and KAD have no disclosures.